• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

GSK plc American Depositary Shares (Each representing two Ordinary Shares) (NY:GSK)

56.69 +0.70 (+1.25%)
Official Closing Price Updated: 7:00 PM EDT, Apr 2, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about GSK plc American Depositary Shares (Each representing two Ordinary Shares)

< Previous 1 2 3 4 5 6 Next >
News headline image
GSK’s RSV Vaccine, AREXVY, Approved in US for Expanded Age Indication in Adults Aged 18–49 Years at Increased Risk
March 13, 2026
From GSK plc
Via Business Wire
News headline image
Bora Pharmaceuticals and GSK Sign $250M Five Year Global Manufacturing Contract
February 23, 2026
From Bora Pharmaceuticals Co., Ltd.
Via Business Wire
News headline image
GSK’s AREXVY Associated With Reductions in Certain RSV-Related Risks Including Heart Attack, Stroke and Severe Flare-Ups of COPD and Asthma, Real World Study Shows
February 18, 2026
From GSK plc
Via Business Wire
News headline image
GSK Awards $2M in COiMMUNITY Initiative Grants to Help Close Vaccination Gaps, Commits $3M for 2026
January 21, 2026
From GSK plc
Via Business Wire
News headline image
GSK Announces Recipients of Linked by Lupus: Optimal Care Initiative Grants Nearing $1 Million
January 20, 2026
From GSK plc
Via Business Wire
News headline image
Exdensur (depemokimab) approved by US FDA for the treatment of severe asthma
December 16, 2025
From GSK plc
Via Business Wire
News headline image
Blenrep approved by US FDA for use in treatment of relapsed/refractory multiple myeloma
October 23, 2025
From GSK plc
Via Business Wire
News headline image
New Local Data in GSK and IQVIA's Vaccine Track Supports Smarter Public Health Action at the Community Level
October 01, 2025
From GSK plc
Via Business Wire
News headline image
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of GSK plc – GSK
September 02, 2025
From Pomerantz LLP
Via GlobeNewswire
News headline image
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of GSK plc – GSK
August 29, 2025
From Pomerantz LLP
Via GlobeNewswire
News headline image
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of GSK plc – GSK
August 21, 2025
From Pomerantz LLP
Via GlobeNewswire
News headline image
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of GSK plc – GSK
August 17, 2025
From Pomerantz LLP
Via GlobeNewswire
News headline image
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of GSK plc – GSK
August 13, 2025
From Pomerantz LLP
Via GlobeNewswire
News headline image
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of GSK plc – GSK
August 09, 2025
From Pomerantz LLP
Via GlobeNewswire
News headline image
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of GSK plc – GSK
August 05, 2025
From Pomerantz LLP
Via GlobeNewswire
News headline image
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of GSK plc – GSK
August 01, 2025
From Pomerantz LLP
Via GlobeNewswire
News headline image
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of GSK plc – GSK
July 28, 2025
From Pomerantz LLP
Via GlobeNewswire
News headline image
GSK sponsors 2025 National Senior Games as part of Sideline RSV campaign to raise awareness of RSV in older adults
July 24, 2025
From GSK plc
Via Business Wire
News headline image
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of GSK plc – GSK
July 23, 2025
From Pomerantz LLP
Via GlobeNewswire
News headline image
US FDA Approves GSK’s SHINGRIX in a Prefilled Syringe Presentation
July 17, 2025
From GSK plc
Via Business Wire
News headline image
GSK begins shipping influenza vaccine doses for the 2025-26 flu season
July 10, 2025
From GSK plc
Via Business Wire
News headline image
FDA approves Benlysta (belimumab) Autoinjector for children with active lupus nephritis
June 24, 2025
From GSK plc
Via Business Wire
News headline image
GSK announces the Linked by Lupus: Optimal Care Initiative to help support individuals with lupus in the US
June 16, 2025
From GSK plc
Via Business Wire
News headline image
Small-Cap Movers Under $1: HIT, SPRO, SGN, PRSO, SGBX Drive Momentum Across AI, Biotech, Crypto, Software, Etc.
May 28, 2025
Via AB Newswire
Topics Artificial Intelligence
News headline image
Nucala (mepolizumab) approved by US FDA for use in adults with chronic obstructive pulmonary disease (COPD)
May 22, 2025
From GSK plc
Via Business Wire
News headline image
GSK and Lifetime® launch original movie to raise awareness about the impact of meningitis
May 09, 2025
From GSK plc
Via Business Wire
News headline image
Alector Announces Completion of Enrollment in the PROGRESS-AD Phase 2 Clinical Trial of AL101/GSK4527226 in Individuals with Early Alzheimer’s Disease
April 17, 2025
From Alector, Inc.
Via GlobeNewswire
News headline image
AREXVY recommended for adults aged 50-59 at increased risk for severe respiratory syncytial virus (RSV) disease by US Advisory Committee on Immunization Practices
April 16, 2025
From GSK plc
Via Business Wire
News headline image
GSK’s 5-in-1 Meningococcal Vaccine PENMENVY Receives Positive Recommendation from US Advisory Committee on Immunization Practices
April 16, 2025
From GSK plc
Via Business Wire
News headline image
GSK Awards $2M in Grant Funding for Programs Supporting Adult Vaccination, Commits Additional $2M for 2025
April 09, 2025
From GSK plc
Via Business Wire
< Previous 1 2 3 4 5 6 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap